Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Investigators develop mouse model for evaluation of anti-human CD37 therapeutics

Jan. 7, 2013

Tumor-suppressing MAb demonstrates preclinical antitumor efficacy

Jan. 4, 2013

Researchers present updated results for CART-19 cell therapy

Jan. 3, 2013

Results published from phase II trial of immunocytokine therapy in melanoma

Dec. 27, 2012

Investigators report results of clinical study testing Wilms tumor protein analogue peptide vaccine

Dec. 24, 2012

CSL-362 shows efficacy in AML animal models

Dec. 24, 2012

Primary endpoint not met in phase III trial of L-BLP25 in NSCLC

Dec. 20, 2012

Genentech presents two antibody-drug conjugates for the treatment of NHL

Dec. 19, 2012

Boehringer Ingelheim's anti-CD33 MAb enters phase I AML study

Dec. 18, 2012

Treatment begins in first phase II trial of IPH-2102 for AML

Dec. 18, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026